Paper Details

  1. Home
  2. Paper Details

A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.

Author: BlaisNormand, EllisPeter M, IonescuDiana N, KashyapMeenakshi, LeighlNatasha B, LiuGeoff, MeloskyBarb, ReimanTony, RomeoPhillippe, ShepherdFrances A, SoulieresDennis, TsaoMing-Sound

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Personalized treatment for non-small cell lung cancer (NSCLC) based on molecular abnormalities is gaining traction. However, the abundance of data and conflicting results create confusion for clinicians.
Paper Details　
Original Abstract of the Article :
Greater understanding of molecular pathways important in cell growth and proliferation of thoracic malignancies, particularly non-small cell lung cancer (NSCLC), has resulted in intense clinical and translational research. There is now considerable interest in personalizing treatment based on an und...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/21709590

データ提供：米国国立医学図書館（NLM）

Personalized Treatment for Lung Cancer: A New Frontier

This study reviews the use of biomarkers in the treatment of non-small cell lung cancer (NSCLC). It's like exploring a vast and complex desert landscape, searching for clues to help guide us towards a better understanding of this disease. The researchers examine the latest research on biomarkers and their potential role in personalized treatment.

Tailoring Treatment to the Individual

The study highlights the potential of using biomarkers to tailor treatment to the individual patient. It's like using a compass to navigate through the desert, ensuring that each traveler takes the most appropriate route. This personalized approach can lead to more effective treatment outcomes and improve patient survival.

The Importance of Research

The study emphasizes the need for ongoing research in this field. It's like a desert expedition that requires constant exploration and discovery to uncover new insights and advance our understanding. This research is crucial for developing new treatments and improving the lives of patients with lung cancer.

Dr. Camel's Conclusion

This study underscores the promise of personalized medicine for lung cancer. It's a reminder that the desert of medicine is always evolving, offering new pathways to discovery and innovation.
Date :
  1. Date Completed 2011-12-15
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

21709590

DOI: Digital Object Identifier

S1556-0864(15)31067-4

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.